Rhonda Klein, MD
Dermatology · Westport, CTNPI 1033386867
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 240 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,060 and has fallen 56.2% since, to $464 in 2025.
Across 240 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$666
- AbbVie$606
- Johnson & Johnson$494
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$470
- Galderma Laboratories, L.p.$241
- LEO Pharma Inc.$227
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,57398%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 38 | $666 |
| AbbVie(2 entities) | 29 | $606 |
| Johnson & Johnson | 18 | $494 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 25 | $470 |
| Galderma Laboratories, L.p. | 15 | $241 |
| LEO Pharma Inc. | 15 | $227 |
| Amgen | 11 | $192 |
| Sanofi | 8 | $188 |
| Novartis | 10 | $167 |
| Dermira, Inc. | 6 | $154 |
| Regeneron Healthcare Solutions, Inc. | 5 | $136 |
| Mayne Pharma Commercial LLC | 8 | $131 |
| Sun Pharmaceutical Industries Inc. | 6 | $116 |
| Arcutis Biotherapeutics, Inc. | 6 | $116 |
| Lilly USA, LLC | 5 | $109 |
| Almirall LLC | 5 | $107 |
| Biofrontera Inc. | 5 | $78 |
| Merz North America, Inc. | 4 | $77 |
| Pfizer | 4 | $60 |
| Sanofi-aventis U.S. LLC | 2 | $48 |
| Organon | 2 | $40 |
| UCB, Inc. | 1 | $37 |
| VYNE Pharmaceuticals Inc. | 2 | $35 |
| Medtronic | 1 | $27 |
| Blueprint Medicines Corporation | 1 | $24 |
| Encore Dermatology Inc. | 1 | $19 |
| Botanix SB Inc | 1 | $19 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $19 |
| Revance Therapeutics, Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Dermavant Sciences, Inc. | 1 | $15 |
| GSK | 1 | $13 |
| Prugen, Inc. Pharmaceuticals | 1 | $11 |
How this compares
$4,673 in reported general payments places this provider in the 60th percentile of 222 dermatology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $48,646 |
| Tretinoin | 30 | $2,134 |
| Clindamycin Phosphate | 18 | $1,304 |
| Spironolactone | 15 | $661 |
| Doxycycline Hyclate | 20 | $487 |
| ValacyclovirValacyclovir Hcl | 29 | $402 |
| Ciclopirox | 15 | $387 |
| Triamcinolone Acetonide | 32 | $315 |
| Nystatin | 19 | $250 |
| Minoxidil | 22 | $229 |
| Hydrocortisone | 27 | $188 |
| Fluconazole | 16 | $130 |
| Mupirocin | 18 | $125 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Westport
- Michael PayetteCromwell$3.2M
- Bruce StroberCromwell$2.9M
- Brett KingFairfield$2.5M
- Mona ShahriariCromwell$2.2M
- Jeremy MossMadison$2M
- Brittany CraiglowFairfield$1.9M
- Meagen McCuskerEnfield$1.8M
- Marcus McFerrenOrange$872K
- Christopher BunickNew Haven$661K
- Keith ChoateNew Haven$362K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.